Red Flags to Spot a Bad Psychedelic Therapist
Psychedelic therapy is becoming more popular, but here are some red flags you can use to spot a bad psychedelic therapist
mdma
Treating Postpartum Depression with Psychedelics
Postpartum depression impacts thousands with no good treatment options. Some people are now treating postpartum depression with psychedelics
Adverse Events in Psychedelic Clinical Trials are Underreported
New research shows that enthusiasm for psychedelic treatments makes it easy to ignore adverse events in psychedelic clinical trials
What’s in the San Francisco Psychedelics Decrim Resolution?
San Francisco becomes the latest city to decriminalize entheogenic plants in another win for Decriminalize Nature
Finding the Messy Middle with Sex and Psychedelics
Combining sex and psychedelics can be fun and adventurous, but it can also be confusing and overwhelming. What happens in the messy middle?
How Long Can the Psychedelic Renaissance Last?
The Psychedelic Renaissance is now in full effect, but how long can the party last? James Kent looks into previous psychedelic movements to find the answer
Psychedelic Clinical Trials and the Michael Pollan Effect
With the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on psychedelic treatments that are not yet available
Three Phase 3 Clinical Trials that Could Legalize Psychedelics
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
Canada Halts MDMA Clinical Trial Over Concerns for Participant Safety
Deficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks
End of content
End of content